{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:11:28Z","timestamp":1789164688282,"version":"build-2803163510"},"reference-count":34,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Qual Saf"],"accepted":{"date-parts":[[2021,9,28]]},"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The associated mortality with COVID-19 has improved compared with the early pandemic period. The effect of hospital COVID-19 patient prevalence on COVID-19 mortality has not been well studied.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We analysed data for adults with confirmed SARS-CoV-2 infection admitted to 62 hospitals within a multistate health system over 12 months. Mortality was evaluated based on patient demographic and clinical risk factors, COVID-19 hospital prevalence and calendar time period of the admission, using a generalised linear mixed model with site of care as the random effect.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>38\u2009104 patients with COVID-19 were hospitalised, and during their encounters, the prevalence of COVID-19 averaged 16% of the total hospitalised population. Between March\u2013April 2020 and January\u2013February 2021, COVID-19 mortality declined from 19% to 12% (p&lt;0.001). In the adjusted multivariable analysis, mid and high COVID-19 inpatient prevalence were associated with a 25% and 41% increase in the odds (absolute contribution to probability of death of 2%\u20133%) of COVID-19 mortality compared with patients with COVID-19 in facilities with low prevalence (&lt;10%), respectively (high prevalence &gt;25%: adjusted OR (AOR) 1.41, 95%\u2009CI 1.23 to 1.61; mid-prevalence (10%\u201325%): AOR 1.25, 95%\u2009CI 1.13 to 1.38). Mid and high COVID-19 prevalence accounted for 76% of patient encounters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Although inpatient mortality for patients with COVID-19 has sharply declined compared with earlier in the pandemic, higher COVID-19 hospital prevalence remained a common risk factor for COVID-19 mortality. Hospital leaders need to reconsider how we provide support to care for patients in times of increased volume and complexity, such as those experienced during COVID-19 surges.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjqs-2021-013721","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T20:27:23Z","timestamp":1633465643000},"page":"45-53","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":17,"title":["COVID-19 hospital prevalence as a risk factor for mortality: an observational study of a multistate cohort of 62 hospitals"],"prefix":"10.1136","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2258-8015","authenticated-orcid":false,"given":"Mohamad Ghazi","family":"Fakih","sequence":"first","affiliation":[{"name":"Clinical & Network Services, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Ottenbacher","sequence":"additional","affiliation":[{"name":"Ascension Data Science Institute, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baligh","family":"Yehia","sequence":"additional","affiliation":[{"name":"Clinical & Network Services, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fogel","sequence":"additional","affiliation":[{"name":"Clinical & Network Services, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Miller","sequence":"additional","affiliation":[{"name":"Ascension Data Science Institute, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3977-6506","authenticated-orcid":false,"given":"Angela","family":"Winegar","sequence":"additional","affiliation":[{"name":"Ascension Data Science Institute, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Jesser","sequence":"additional","affiliation":[{"name":"Ascension Clinical Research Institute, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Cacchione","sequence":"additional","affiliation":[{"name":"Clinical & Network Services, Ascension Health, Saint Louis, Missouri, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"2025090411104835000_31.1.45.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001191"},{"key":"2025090411104835000_31.1.45.2","unstructured":"Johns Hopkins University Center for Systems Science and Engineering . United States coronavirus (2019-nCoV) cases. Available: https:\/\/gisanddata.maps.arcgis.com\/apps\/opsdashboard\/index.html#\/bda7594740fd40299423467b48e9ecf6 [Accessed 25 Aug 2021]."},{"key":"2025090411104835000_31.1.45.3","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.6556"},{"key":"2025090411104835000_31.1.45.4","doi-asserted-by":"crossref","first-page":"e218828","DOI":"10.1001\/jamanetworkopen.2021.8828","article-title":"Trends in patient characteristics and COVID-19 in-hospital mortality in the United States during the COVID-19 pandemic","volume":"4","author":"Roth","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025090411104835000_31.1.45.5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12788\/jhm.3552","article-title":"Trends in COVID-19 risk-adjusted mortality rates","volume":"16","author":"Horwitz","year":"2021","journal-title":"J Hosp Med"},{"key":"2025090411104835000_31.1.45.6","doi-asserted-by":"crossref","first-page":"e2034266","DOI":"10.1001\/jamanetworkopen.2020.34266","article-title":"Association of intensive care unit patient load and demand with mortality rates in US department of veterans affairs hospitals during the COVID-19 pandemic","volume":"4","author":"Bravata","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025090411104835000_31.1.45.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436"},{"key":"2025090411104835000_31.1.45.8","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of hydroxychloroquine in hospitalized patients with Covid-19","volume":"383","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"2025090411104835000_31.1.45.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"2025090411104835000_31.1.45.10","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003763"},{"key":"2025090411104835000_31.1.45.11","unstructured":"National Institutes of Health . COVID-19 treatment guidelines panel. coronavirus disease 2019 (COVID-19) treatment guidelines. Available: https:\/\/www.covid19treatmentguidelines.nih.gov\/ [Accessed 04 May 2021]."},{"key":"2025090411104835000_31.1.45.12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13054-021-03504-w","article-title":"Surge effects and survival to hospital discharge in critical care patients with COVID-19 during the early pandemic: a cohort study","volume":"25","author":"Dale","year":"2021","journal-title":"Crit Care"},{"key":"2025090411104835000_31.1.45.13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(07)61602-x"},{"key":"2025090411104835000_31.1.45.14","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199801000-00004"},{"key":"2025090411104835000_31.1.45.15","doi-asserted-by":"publisher","DOI":"10.21105\/joss.00648"},{"key":"2025090411104835000_31.1.45.16","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000735"},{"key":"2025090411104835000_31.1.45.17","unstructured":"Agency for toxic substances and disease registry . CDC\/ATSDR social vulnerability index (SVI). Available: https:\/\/www.atsdr.cdc.gov\/placeandhealth\/svi\/ [Accessed 02 May 2021]."},{"key":"2025090411104835000_31.1.45.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.hjdsi.2020.100489","article-title":"Hospital and ICU patient volume per physician at peak of COVID pandemic: State-level estimates","volume":"8","author":"Bhatla","year":"2020","journal-title":"Healthc"},{"key":"2025090411104835000_31.1.45.19","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/S1473-3099(20)30458-8","article-title":"Monitoring approaches for health-care workers during the COVID-19 pandemic","volume":"20","author":"Bielicki","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2025090411104835000_31.1.45.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3582"},{"key":"2025090411104835000_31.1.45.21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201304-0622OC"},{"key":"2025090411104835000_31.1.45.22","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.1303"},{"key":"2025090411104835000_31.1.45.23","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1377\/hlthaff.2020.01269","article-title":"Severe staffing and personal protective equipment shortages faced by nursing homes during thstaffing and personal protective equipment shortages faced by nursing homes during the covid-19 pandemic","volume":"39","author":"McGarry","year":"2020","journal-title":"Health Aff"},{"key":"2025090411104835000_31.1.45.24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/inr.12598","article-title":"Challenging times: ethics, nursing and the COVID-19 pandemic","volume":"67","author":"Turale","year":"2020","journal-title":"Int Nurs Rev"},{"key":"2025090411104835000_31.1.45.25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2020-011512"},{"key":"2025090411104835000_31.1.45.26","doi-asserted-by":"crossref","unstructured":"Gray BM , Vandergrift JL , Barnhart BJ , et al . Changes in stress and workplace shortages reported by U.S. critical care physicians treating coronavirus disease 2019 patients. Crit Care Med 2021;Publish Ahead of Print.doi:10.1097\/CCM.0000000000004974","DOI":"10.1097\/CCM.0000000000004974"},{"key":"2025090411104835000_31.1.45.27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1213\/ANE.0000000000004849","article-title":"Staffing with disease-based epidemiologic indices may reduce shortage of intensive care unit staff during the COVID-19 pandemic","volume":"131","author":"Mascha","year":"2020","journal-title":"Anesth Analg"},{"key":"2025090411104835000_31.1.45.28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.amjmed.2020.10.026","article-title":"Will the traditional physical examination be another casualty of COVID-19?","volume":"134","author":"Gelfman","year":"2021","journal-title":"Am J Med"},{"key":"2025090411104835000_31.1.45.29","first-page":"e0168","article-title":"Relocating IV pumps for critically ill isolated coronavirus disease 2019 patients from bedside to outside the patient room","volume":"2","author":"Shah","year":"2020","journal-title":"Crit Care Explor"},{"key":"2025090411104835000_31.1.45.30","first-page":"1","article-title":"Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): the urgent need to refocus on hardwiring prevention efforts","author":"Fakih","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2025090411104835000_31.1.45.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"2025090411104835000_31.1.45.32","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"2025090411104835000_31.1.45.33","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.18039"},{"key":"2025090411104835000_31.1.45.34","doi-asserted-by":"publisher","DOI":"10.1186\/s12960-020-00529-0"}],"container-title":["BMJ Quality &amp; Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjqs-2021-013721","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T18:20:01Z","timestamp":1757010001000},"score":1,"resource":{"primary":{"URL":"https:\/\/qualitysafety.bmj.com\/lookup\/doi\/10.1136\/bmjqs-2021-013721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12,16]]},"published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/bmjqs-2021-013721"],"URL":"https:\/\/doi.org\/10.1136\/bmjqs-2021-013721","relation":{},"ISSN":["2044-5415","2044-5423"],"issn-type":[{"value":"2044-5415","type":"print"},{"value":"2044-5423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,5]]}}}